Global Computational Biology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Computational Biology Market is presumed to reach the market size of nearly USD 20.3 Billion by 2032 from USD 6.36 Billion in 2023 with a CAGR of 13.76% under the study period 2024-2032.

Computational biology is an interdisciplinary field that utilizes computational techniques to understand and model biological systems and processes. It involves developing and applying algorithms, mathematical models, and software tools to analyze complex biological data, such as genomic sequences, protein structures, and cellular interactions. This field is essential for interpreting large-scale biological datasets, enabling genomics, proteomics, and systems biology advancements. This facilitates the discovery of new drug targets, the design of personalized medicine strategies, and the insight into the molecular mechanisms of diseases. Integrating computational methods with biological research supports the advancement of both basic and applied sciences, driving innovation in drug discovery, medical diagnostics, and therapeutic development.

MARKET DYNAMICS

The computational biology market is propelled by the exponential growth in biological data generated from genomics and proteomics research, which necessitates sophisticated computational tools to manage and analyze this information. The increasing adoption of personalized medicine & targeted therapies drives demand for advanced computational models that predict patient-specific treatment responses. Moreover, advancements in artificial intelligence & machine learning are enhancing the capabilities of computational biology tools, allowing for more accurate predictions & insights into complex biological systems. The rise in government and private sector investments in biotechnology and healthcare research further fuels market growth. Collaborations between research institutions and technology companies also foster innovation in computational biology applications. Additionally, the need for efficient drug discovery and development processes creates opportunities for computational approaches to streamline these activities, thereby accelerating the pace of medical advancements. However, the high cost of advanced computational tools and the complexity of integrating diverse biological data may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Computational Biology. The growth and trends of Computational Biology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Computational Biology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

Databases
Infrastructure & Hardware
Software Platform

By Application

Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization)
Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics)
Clinical Trial (Phase I, Phase II, Phase III, Phase IV)
Computational Genomics
Computational Proteomics
Others

By End-use

Academic & Research
Industrial

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Computational Biology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Computational Biology market include DNAnexus, Illumina, Thermo Fisher Scientific, Schrodinger, Compugen, Aganitha AI Inc., Genedata AG, Qiagen, Simulations Plus Inc. Fios Genomics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112115581

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. COMPUTATIONAL BIOLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Service
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY SERVICE

5.1. Overview By Service
5.2. Historical and Forecast Data Analysis By Service
5.3. Databases Historic and Forecast Sales By Regions
5.4. Infrastructure & Hardware Historic and Forecast Sales By Regions
5.5. Software Platform Historic and Forecast Sales By Regions

6. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization) Historic and Forecast Sales By Regions
6.4. Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics) Historic and Forecast Sales By Regions
6.5. Clinical Trial (Phase I, Phase II, Phase III, Phase IV) Historic and Forecast Sales By Regions
6.6. Computational Genomics Historic and Forecast Sales By Regions
6.7. Computational Proteomics Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Academic & Research Historic and Forecast Sales By Regions
7.4. Industrial Historic and Forecast Sales By Regions

8. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE COMPUTATIONAL BIOLOGY COMPANIES

9.1. Computational Biology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF COMPUTATIONAL BIOLOGY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. DNAnexus
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Illumina
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Thermo Fisher Scientific
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Schrodinger
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Compugen
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Aganitha AI Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Genedata AG
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Qiagen
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Simulations Plus Inc. Fios Genomics
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies